Skip to content

The clinical efficacy of umbilical acupuncture in the treatment of dry eye syndrome and its influence on ocular surface function

The clinical efficacy of umbilical acupuncture in the treatment of dry eye syndrome and its influence on ocular surface function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000855
Enrollment
Unknown
Registered
2025-04-27
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye syndrome

Interventions

Treatment group:?Acupuncture Points?: Eye Point, Kun, Dui, and Kan positions at the umbilicus (Shenque, CV8). ?Localization?: As per Umbilical Acupuncture Primer by Prof. Qi Yong.
control group:Treatment was administered with 0.1% sodium hyaluronate eye drops. The course of treatment was four times a day, one drop each time, used in the morning, at noon, in the evening and befo

Sponsors

Hangzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) The selected patients met the diagnostic criteria for dry eye syndrome and both eyes were diagnosed with dry eye. (2) They had not received any other dry eye treatment for at least one month. (3) All patients agreed to participate in this experimental study and signed the informed consent form and were able to ensure timely and accurate data reporting. (4) They were conscious with normal intelligence and communication abilities. ?(5) Individuals aged 18-70 years.

Exclusion criteria

Exclusion criteria: (1) Those with ocular surface diseases such as keratoconjunctivitis and chalazion; (2) Those with skin damage or blisters around the umbilicus; (3) Those with dry eye syndrome caused by physical disorders such as hyperthyroidism Sjogren's syndrome systemic lupus erythematosus or by certain primary lesions severe ocular thermal burns ocular chemical burns or within three months after ophthalmic surgery or within six months after ocular trauma; (4) Those with severe mental disorders or infectious diseases and pregnant women; (5) Patients with severe heart liver lung or kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
Ocular Surface Disease Index;

Secondary

MeasureTime frame
Fluorescein Staining;Corneal sensation;Tear Meniscus Height;Corneal topography;Tear Film Break-up Time;Meibomian gland function score;Schirmer I Test;

Countries

China

Contacts

Public ContactYehua Bao

Hangzhou Hospital of Traditional Chinese Medicine

13336101400@163.com18958076121

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026